OrbiMed
About OrbiMed
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Investment focus
Stages
Sectors
Portfolio (22 in our database)
XtalPiXtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.Series D · $786M raisedPionyr ImmunotherapeuticsPionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.Corporate Round · $352M raisedACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.Series B · $258M raisedAspen NeuroscienceAspen Neuroscience is a biotechnology company that uses innovative genomic approaches combined with stem cell biology.Series B · $224M raisedBinx HealthBinx Health creates new categories of healthcare solutions that deliver on-demand testing to people where they need it most.Series E · $220M raisedOdyssey TherapeuticsOdyssey Therapeutics provides medicines to patients with inflammatory diseases and cancer.Series A · $218M raisedGentiBioGentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.Series A · $177M raisedReCode TherapeuticsReCode Therapeutics is a genetic medicines company developing targeted, disease-modifying therapies for life-limiting respiratory diseases.Series B · $162M raisedArriVent BiopharmaArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.Series A · $150M raisedAdicet BioAdicet Bio is a biotechnology company that designs and develops of off-the-shelf allogeneic gamma delta T cell therapies.Series B · $146M raisedEnliven TherapeuticsEnliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.Series B · $140M raisedTurnstone BiologicsTurnstone Biologics is a privately-held clinical stage biotech company.Series D · $133M raisedScribe TherapeuticsScribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.Series B · $120M raisedCarrot FertilityCarrot Fertility helps employers offer their workers fertility benefits that are flexible, transparent, and cost-conscious.Series C · $114M raisedSionna TherapeuticsSionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).Series B · $110M raisedQ32 BioQ32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.Series B · $106M raisedElectra TherapeuticsElectra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.Series B · $100M raisedCrown BioscienceCrownBio is helping provide clarity of action in the fight against cancer and diabetes.Acquired · $62M raisedEntosEntos uses machine learning-technology for energy and force evaluations required for R&D labs.Series A · $53M raisediECUREiECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.Series A · $50M raisedCyrus BiotechnologyCyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.Series B · $47M raisedGennao BioGennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.Series A · $41M raised